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Background/Introduction: Regulatory T (Treg) cells have been implicated in 
atherosclerosis pathogenesis but the mechanisms involved remain poorly 
defined. Potent suppressive capacity constitutes the most important and 
defining Treg feature. Data on Treg frequency in atherosclerosis patients is 
contradictory: some studies found reduced frequencies; others suggested that 
Treg frequency does not correlate with atherosclerosis severity; and other 
studies suggested that Treg reduction increases myocardial infarction (MI) 
risk. Information on Treg suppressive function in atherosclerosis patients is 
even scarcer.  
Purpose: We aimed to characterise Treg frequency, phenotype and function 
in atherosclerosis patients. 
Methods: CD4+CD25highCD127lowFOXP3+ Treg were quantified in 
atherosclerosis patients (myocardial infarction (MI), n=60; stable angina, SA, 
n=40), and in healthy subjects (n=30) by flow cytometry. Sorted Treg from 
atherosclerosis patients and controls were used for direct and cross-
suppression assays. 
Results: Treg number was significantly lower in MI and SA patients 
compared to healthy subjects. This was due to reduction of naive 
Foxp3lowCD45RAhigh Treg (p<0.0001), while effector Foxp3highCD45RAlow Treg 
were not affected. Moreover, we found a significant increase in cytokine-
producing Foxp3lowCD45RAlow Treg (p<0.0001). Strikingly, suppression 
assays demonstrated that Treg from MI patients display enhanced 
suppressive function compared to Treg from healthy individuals, in line with 
increased effector/resting Treg ratio in MI. In depth phenotypic and functional 
characterisation of Treg subsets to identify mechanisms responsible for 
altered frequency and suppressive activity is ongoing. 
Conclusions: Our data indicate that Treg from atherosclerosis patients are 
potent suppressors and have pro-inflammatory phenotype and functions. 
These results contrast previous findings that suggested decreased Treg 
suppressive function in MI. Our results reveal a complex role for Treg in 
human atherosclerosis beyond generic suppression of inflammation into 
dynamic cells that exhibit pathogenic traits. 
 
 
